Atlas Trials

Low-dose ITI Strategy for Children in Hemophilia A With High-titer Inhibitor and Poor ITI Risk in China

Clinical trial NCT03598725 · UNKNOWN

Trial details

NCT number
NCT03598725
Sponsor
Beijing Children's Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hemophilia A With Inhibitor
Start date
2016-01-01
Primary completion
2019-12-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.